NIO vs STRO · rev $12.51B vs rev $62.0M
Nio Inc Class A ADR (NIO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
NIO currently screens at market cap $7.61B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the NIO and STRO stock pages for the full models.
Not investment advice.